Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -2.31% | 324.21 | 0.0% | $4670.09m | |
| BNTX | BioNTech SE | -1.06% | 247.68 | 0.0% | $730.32m | |
| NVAX | Novavax, Inc. | -4.59% | 161.95 | 79.4% | $715.24m | |
| AMGN | Amgen, Inc. | 0.51% | 207.84 | 1.4% | $575.65m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -7.57% | 6.47 | 0.7% | $452.28m | |
| GILD | Gilead Sciences, Inc. | -0.76% | 67.63 | 1.0% | $426.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.43% | 553.24 | 2.7% | $408.99m | |
| ILMN | Illumina, Inc. | 0.45% | 409.93 | 3.3% | $392.87m | |
| CCXI | ChemoCentryx, Inc. | -7.04% | 34.47 | 2.9% | $387.64m | |
| XLRN | Acceleron Pharma, Inc. | 0.50% | 172.94 | 5.3% | $345.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.07% | 181.77 | 1.9% | $259.59m | |
| BIIB | Biogen, Inc. | -1.43% | 281.19 | 1.7% | $243.39m | |
| OCGN | Ocugen, Inc. | -13.83% | 8.66 | 0.0% | $178.37m | |
| XENE | Xenon Pharmaceuticals, Inc. | 2.12% | 33.66 | 0.4% | $178.19m | |
| JSPR | Jasper Therapeutics, Inc. | 31.57% | 16.42 | 0.0% | $158.53m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.